chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dyspnea (shortness of breath), pain in extremity (sore arm), peripheral swelling (swollen arm), pyrexia (low-grade fever) and headache in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Patient was negative for past history of COVID-19 diagnosis. On Mar 16, 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 16, 2021, patient experienced dyspnea (shortness of breath), pain in extremity (sore arm), peripheral swelling (swollen arm), pyrexia (low-grade fever) and headache. The patient was treated with ibuprofen at an unspecified dose and frequency. At the time of the report, dyspnea (shortness of breath), pain in extremity (sore arm), peripheral swelling (swollen arm), pyrexia (low-grade fever) and headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: patches quilt like on both arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (patches quilt like on both arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (patches quilt like on both arms). At the time of the report, RASH (patches quilt like on both arms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   No treatment was taken by the patient for the event.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), FATIGUE (fatigue) and HEADACHE (headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical information history was reported.  Concomitant products included IBUPROFEN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAIN (pain), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, PAIN (pain), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication also included an unspecified blood pressure medication.  Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Malaise, Pain in extremity, Swelling, Urticaria
Clinical narrative: red hive; pretty swollen; warm to touch; little sore; not feeling up to herself,doesn't feel not quite well; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (red hive), SWELLING (pretty swollen), FEELING HOT (warm to touch), PAIN IN EXTREMITY (little sore) and MALAISE (not feeling up to herself,doesn't feel not quite well) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 031M20A) for COVID-19 vaccination.     No medical information history was reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO ELLIPTA), MONTELUKAST SODIUM (SINGULAIR), ALBUTEROL [SALBUTAMOL], SALBUTAMOL (ALBUTEROL HFA) and ELUXADOLINE (VIBERZI) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced URTICARIA (red hive), SWELLING (pretty swollen), FEELING HOT (warm to touch), PAIN IN EXTREMITY (little sore) and MALAISE (not feeling up to herself,doesn't feel not quite well). At the time of the report, URTICARIA (red hive), SWELLING (pretty swollen), FEELING HOT (warm to touch), PAIN IN EXTREMITY (little sore) and MALAISE (not feeling up to herself,doesn't feel not quite well) outcome was unknown.            Patient did not took any treatment for the events.    This case was linked to MOD-2021-047754 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Heart rate, Pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (body aches), PYREXIA (fever of 103) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Crohn's disease. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) and SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN (body aches), PYREXIA (fever of 103) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body aches) and PYREXIA (fever of 103) had resolved and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 103 (High) fever of 103F. On 15-Feb-2021, Heart rate: 85 (High) elevated heart rate of 85 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (little pain for 2 days) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PAIN (little pain for 2 days). On 28-Jan-2021, PAIN (little pain for 2 days) had resolved. Not Provided          No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-047936 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: The follow up received was NNI.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Peripheral swelling, Pruritus, Rash
Clinical narrative: she still has some eruptions on her legs and stomach; headache; hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad; itching really bad; her face swelled up, like a big pumpkin; severe cramping in her back and some in her stomach; her whole left arm swelled up and was humongous; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole left arm swelled up and was humongous), URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin) and MUSCLE SPASMS (severe cramping in her back and some in her stomach) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Kidney cancer, Solitary kidney, COPD, Asthma, Arthritis, Hypertension, Anxiety and Difficulty sleeping. Concomitant products included TRAMADOL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (her whole left arm swelled up and was humongous). On 04-Mar-2021, the patient experienced URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin), MUSCLE SPASMS (severe cramping in her back and some in her stomach) and HEADACHE (headache). On an unknown date, the patient experienced RASH (she still has some eruptions on her legs and stomach). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 11-Mar-2021, PERIPHERAL SWELLING (her whole left arm swelled up and was humongous), URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin), MUSCLE SPASMS (severe cramping in her back and some in her stomach) and HEADACHE (headache) had resolved. At the time of the report, RASH (she still has some eruptions on her legs and stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication included unspecified medicines for heart, anxiety, sleep and high blood pressure.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Urticaria
Clinical narrative: she still has some eruptions on her legs and stomach; headache; hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad; itching really bad; her face swelled up, like a big pumpkin; severe cramping in her back and some in her stomach; her whole left arm swelled up and was humongous; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole left arm swelled up and was humongous), URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin) and MUSCLE SPASMS (severe cramping in her back and some in her stomach) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Kidney cancer, Solitary kidney, COPD, Asthma, Arthritis, Hypertension, Anxiety and Difficulty sleeping. Concomitant products included TRAMADOL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (her whole left arm swelled up and was humongous). On 04-Mar-2021, the patient experienced URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin), MUSCLE SPASMS (severe cramping in her back and some in her stomach) and HEADACHE (headache). On an unknown date, the patient experienced RASH (she still has some eruptions on her legs and stomach). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 11-Mar-2021, PERIPHERAL SWELLING (her whole left arm swelled up and was humongous), URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin), MUSCLE SPASMS (severe cramping in her back and some in her stomach) and HEADACHE (headache) had resolved. At the time of the report, RASH (she still has some eruptions on her legs and stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication included unspecified medicines for heart, anxiety, sleep and high blood pressure.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site pruritus
Clinical narrative: Red Rash on the Left Upper Arm (About 5"); Itching Injection Site (About 5"); This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red Rash on the Left Upper Arm (About 5")) and VACCINATION SITE PRURITUS (Itching Injection Site (About 5")) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Red Rash on the Left Upper Arm (About 5")) and VACCINATION SITE PRURITUS (Itching Injection Site (About 5")). The patient was treated with DIPHENHYDRAMINE at an unspecified dose and frequency. On 12-Mar-2021, VACCINATION SITE PRURITUS (Itching Injection Site (About 5")) had resolved. On 15-Mar-2021, RASH ERYTHEMATOUS (Red Rash on the Left Upper Arm (About 5")) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Additional information was received on 06-May-2021 added contact information and dose 2 received.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Headache, Vomiting
Clinical narrative: Hot; Vomiting; Tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot), VOMITING (Vomiting), FATIGUE (Tired) and HEADACHE (headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FEELING HOT (Hot), VOMITING (Vomiting), FATIGUE (Tired) and HEADACHE (headache). At the time of the report, FEELING HOT (Hot), VOMITING (Vomiting), FATIGUE (Tired) and HEADACHE (headache) outcome was unknown.            No concomitant medications were provided by the reporter.   Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pain, Pain in extremity, Skin swelling, Swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (arm was sore), skin swelling (puffy in the area where shot was given), swelling (swollen), skin swelling (all puffy) and pain (sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 032M20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. Concomitant products included vitamins (NOS) for an unknown indication. On Mar 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 8, 2021, patient experienced pain in extremity (arm was sore), skin swelling (puffy in the area where shot was given) and vaccination site induration (little hard). On Mar 17, 2021, patient experienced swelling (swollen), skin swelling (all puffy), pain (sore) and induration (all hard). At the time of the report, pain in extremity (arm was sore), skin swelling (puffy in the area where shot was given) and vaccination site induration (little hard) had resolved and swelling (swollen), skin swelling (all puffy), pain (sore) and induration (all hard) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Patient did not take any treatment for the events.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (arm was sore), skin swelling (puffy in the area where shot was given), swelling (swollen), skin swelling (all puffy) and pain (sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 032M20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. Concomitant products included vitamins (NOS) for an unknown indication. On Mar 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 8, 2021, patient experienced pain in extremity (arm was sore), skin swelling (puffy in the area where shot was given) and vaccination site induration (little hard). On Mar 17, 2021, patient experienced swelling (swollen), skin swelling (all puffy), pain (sore) and induration (all hard). At the time of the report, pain in extremity (arm was sore), skin swelling (puffy in the area where shot was given) and vaccination site induration (little hard) had resolved and swelling (swollen), skin swelling (all puffy), pain (sore) and induration (all hard) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Patient did not take any treatment for the events.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site induration, Injection site mass, Injection site pain
Clinical narrative: Lump injection site; Hard injection site; Itchy injection site; Redness injection site; Swollen injection site; Pain injection site; tired; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site) and INJECTION SITE SWELLING (Swollen injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site), INJECTION SITE SWELLING (Swollen injection site), INJECTION SITE PAIN (Pain injection site), FATIGUE (tired) and NAUSEA (nausea). At the time of the report, INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site), INJECTION SITE SWELLING (Swollen injection site), INJECTION SITE PAIN (Pain injection site), FATIGUE (tired) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Outcome for the all the events has been updated from unknown to recovered and patient declined further follow-up
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Nausea
Clinical narrative: Lump injection site; Hard injection site; Itchy injection site; Redness injection site; Swollen injection site; Pain injection site; tired; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site) and INJECTION SITE SWELLING (Swollen injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site), INJECTION SITE SWELLING (Swollen injection site), INJECTION SITE PAIN (Pain injection site), FATIGUE (tired) and NAUSEA (nausea). At the time of the report, INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site), INJECTION SITE SWELLING (Swollen injection site), INJECTION SITE PAIN (Pain injection site), FATIGUE (tired) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Outcome for the all the events has been updated from unknown to recovered and patient declined further follow-up
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Hyperhidrosis, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Labored breathing), HYPERHIDROSIS (Profusely sweating), CHILLS (Extreme chills) and VOMITING (vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical information history was reported.  Concomitant products included LIRAGLUTIDE (VICTOZA), APIXABAN (ELIQUIS), METOPROLOL, SERTRALINE, AMLODIPINE, BUPROPION, ATORVASTATIN, TRIAMTERENE, ACETAMIDE and GLIMEPIRIDE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DYSPNOEA (Labored breathing), HYPERHIDROSIS (Profusely sweating), CHILLS (Extreme chills) and VOMITING (vomiting). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 01-Mar-2021, DYSPNOEA (Labored breathing), HYPERHIDROSIS (Profusely sweating), CHILLS (Extreme chills) and VOMITING (vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 100.9,) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included IBUPROFEN.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PYREXIA (fever of 100.9,). At the time of the report, PYREXIA (fever of 100.9,) outcome was unknown. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Body temperature: 101.0 (High) temperature now reads 101.0 on one thermometer and 100.0 on a different thermometer.. On 17-Mar-2021, Pyrexia: 100.9 (High) fever of 100.9.         Reporter did not provide any other AE information.    Action taken with mRNA-1273 in response to the events were not applicable.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Headache; Chills; Joint pain; Muscle pain; she get the second vaccine three months later; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later). At the time of the report, HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was given.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Significant follow up appended. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she get the second vaccine three months later). At the time of the report, HEADACHE (Headache), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was given.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Significant follow up appended.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood pressure measurement, Dizziness, Glycosylated haemoglobin, Heart rate
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included LOSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy), PAIN IN EXTREMITY (Sore arm), MYALGIA (Muscle pain in her right arm) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced PARAESTHESIA (Tingling in both arms / Tingling in right leg / Tingling in the neck / Tingling in the back). The patient was treated with HYDROXOCOBALAMIN (VITAMIN B12 [HYDROXOCOBALAMIN]) for Symptomatic treatment, at an unspecified dose and frequency and VITAMIN C [ASCORBIC ACID] for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy), PAIN IN EXTREMITY (Sore arm), PARAESTHESIA (Tingling in both arms / Tingling in right leg / Tingling in the neck / Tingling in the back), MYALGIA (Muscle pain in her right arm) and NAUSEA (Nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Blood pressure measurement: high (High) High. On 06-Mar-2021, Glycosylated haemoglobin: elevated (High) Elevated.. On 06-Mar-2021, Heart rate: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information also included to take more fluids.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Myalgia, Nausea, Pain in extremity, Paraesthesia
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included LOSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy), PAIN IN EXTREMITY (Sore arm), MYALGIA (Muscle pain in her right arm) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced PARAESTHESIA (Tingling in both arms / Tingling in right leg / Tingling in the neck / Tingling in the back). The patient was treated with HYDROXOCOBALAMIN (VITAMIN B12 [HYDROXOCOBALAMIN]) for Symptomatic treatment, at an unspecified dose and frequency and VITAMIN C [ASCORBIC ACID] for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy), PAIN IN EXTREMITY (Sore arm), PARAESTHESIA (Tingling in both arms / Tingling in right leg / Tingling in the neck / Tingling in the back), MYALGIA (Muscle pain in her right arm) and NAUSEA (Nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Blood pressure measurement: high (High) High. On 06-Mar-2021, Glycosylated haemoglobin: elevated (High) Elevated.. On 06-Mar-2021, Heart rate: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information also included to take more fluids.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.  Concomitant products included LOSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy), PAIN IN EXTREMITY (Sore arm), MYALGIA (Muscle pain in her right arm) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced PARAESTHESIA (Tingling in both arms / Tingling in right leg / Tingling in the neck / Tingling in the back). The patient was treated with HYDROXOCOBALAMIN (VITAMIN B12 [HYDROXOCOBALAMIN]) for Symptomatic treatment, at an unspecified dose and frequency and VITAMIN C [ASCORBIC ACID] for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (Hot flashes), SLUGGISHNESS (Sluggish), ABDOMINAL DISCOMFORT (Swishy stomach), DIZZINESS (Dizzy), PAIN IN EXTREMITY (Sore arm), PARAESTHESIA (Tingling in both arms / Tingling in right leg / Tingling in the neck / Tingling in the back), MYALGIA (Muscle pain in her right arm) and NAUSEA (Nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Blood pressure measurement: high (High) High. On 06-Mar-2021, Glycosylated haemoglobin: elevated (High) Elevated.. On 06-Mar-2021, Heart rate: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information also included to take more fluids.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling, Pruritus
Clinical narrative: Felt little pain; Arm is swollen; Redness is getting bigger; Itchy around redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Felt little pain), PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Redness is getting bigger) and PRURITUS (Itchy around redness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included CALCIUM and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (Felt little pain), PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Redness is getting bigger) and PRURITUS (Itchy around redness). At the time of the report, PAIN (Felt little pain), PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Redness is getting bigger) and PRURITUS (Itchy around redness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included cold compress.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Full body rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Full body rash) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) and PREDNISONE for Eye abnormality NOS, APIXABAN (ELIQUIS), METOPROLOL, TIMOLOL, LATANOPROST, CALCIUM, COLECALCIFEROL (CALCIUM WITH D3), MAGNESIUM and SHARK CARTILAGE for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced RASH (Full body rash). The patient was treated with PARAFFIN, LIQUID, PETROLATUM, WOOL FAT (EUCERIN [PARAFFIN, LIQUID;PETROLATUM;WOOL FAT]) at an unspecified dose and frequency. At the time of the report, RASH (Full body rash) outcome was unknown. Not Provided          Patient did not experience any itching or any other side effects just a rash all over her torso and down her arms and inner legs. She used Eucerin cream for rash.   This case was linked to MOD-2021-047786 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Arm Pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain) and HEADACHE (Headache). On 07-Mar-2021, PAIN IN EXTREMITY (Arm Pain) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was not provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Vaccination site pain, Vaccination site swelling
Clinical narrative: Pain at injection iste; Swelling at injection site; Lightheadedness; Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Pain at injection iste), VACCINATION SITE SWELLING (Swelling at injection site), DIZZINESS (Lightheadedness) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection iste), VACCINATION SITE SWELLING (Swelling at injection site), DIZZINESS (Lightheadedness) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE PAIN (Pain at injection iste), VACCINATION SITE SWELLING (Swelling at injection site), DIZZINESS (Lightheadedness) and FATIGUE (Fatigue) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable.  No concomitant medications were provided.  No treatment medications were provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Feeling abnormal, Hyperglycaemia, Insomnia
Clinical narrative: High fasting blood sugar; Felt off; Couldn't sleep; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (High fasting blood sugar), FEELING ABNORMAL (Felt off) and INSOMNIA (Couldn't sleep) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus and Anxiety. Concomitant products included METFORMIN for Type 2 diabetes mellitus.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced HYPERGLYCAEMIA (High fasting blood sugar), FEELING ABNORMAL (Felt off) and INSOMNIA (Couldn't sleep). On 06-Mar-2021, HYPERGLYCAEMIA (High fasting blood sugar), FEELING ABNORMAL (Felt off) and INSOMNIA (Couldn't sleep) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Blood glucose: 180 mg/dl (High) The morning after receiving the vaccine patient's fasting blood sugars were "sky high", in the 180's, 174, 179 and it would last throughout the day as well..         Treatment information was not provided. Patient wears a diabetic sensor. Patient's normal fasting blood sugar is around 107. Patient noticed that fasting blood sugars altered with both the doses. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-047708 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter contact information updated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pruritus, Rash
Clinical narrative: Did not get 2nd Vaccine as scheduled; rash head to toe/rash on chest/Rash over arms; Very bad itch; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Very bad itch), PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Vaccine as scheduled), RASH (Rash) and RASH (rash head to toe/rash on chest/Rash over arms) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included ADALIMUMAB (HUMIRA AC), LEVOTHYROXINE SODIUM (SYNTHROID), MONTELUKAST, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and METHOTREXATE SODIUM (MTX DURA) for an unknown indication, AVOBENZONE, OCTINOXATE (SUNSCREEN), FOLIC ACID, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and CALCIUM.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PRURITUS (Very bad itch) and RASH (Rash). On 29-Mar-2021, the patient experienced RASH (rash head to toe/rash on chest/Rash over arms). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Vaccine as scheduled). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. On 22-Apr-2021, RASH (rash head to toe/rash on chest/Rash over arms) had not resolved. At the time of the report, PRURITUS (Very bad itch) and PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Vaccine as scheduled) had resolved and RASH (Rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes steroids   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Medical history, concomitant medication and new events were added
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Rash
Clinical narrative: Swelling of his top lip; Swelling of his bottom lip; Rash on back of neck, arms and legs; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swelling of his bottom lip), LIP SWELLING (Swelling of his top lip) and RASH (Rash on back of neck, arms and legs) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history information was provided.     On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced RASH (Rash on back of neck, arms and legs). On 15-Mar-2021, the patient experienced LIP SWELLING (Swelling of his bottom lip). On 17-Mar-2021, the patient experienced LIP SWELLING (Swelling of his top lip). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 16-Mar-2021, LIP SWELLING (Swelling of his bottom lip) had resolved. At the time of the report, LIP SWELLING (Swelling of his top lip) and RASH (Rash on back of neck, arms and legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Hypersensitivity, Illness, Pain in extremity
Clinical narrative: Itching all over the body; Worsened her allergies; Pain in arms; brain fogged; Felt sick; tired; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body), HYPERSENSITIVITY (Worsened her allergies), PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (brain fogged) and ILLNESS (Felt sick) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (Itching all over the body), HYPERSENSITIVITY (Worsened her allergies), PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (brain fogged), ILLNESS (Felt sick) and FATIGUE (tired). On 08-Mar-2021, PAIN IN EXTREMITY (Pain in arms) had resolved. At the time of the report, PRURITUS (Itching all over the body), HYPERSENSITIVITY (Worsened her allergies), FEELING ABNORMAL (brain fogged), ILLNESS (Felt sick) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information were provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Outcome of event fatigue was updated.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching all over the body; Worsened her allergies; Pain in arms; brain fogged; Felt sick; tired; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body), HYPERSENSITIVITY (Worsened her allergies), PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (brain fogged) and ILLNESS (Felt sick) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (Itching all over the body), HYPERSENSITIVITY (Worsened her allergies), PAIN IN EXTREMITY (Pain in arms), FEELING ABNORMAL (brain fogged), ILLNESS (Felt sick) and FATIGUE (tired). On 08-Mar-2021, PAIN IN EXTREMITY (Pain in arms) had resolved. At the time of the report, PRURITUS (Itching all over the body), HYPERSENSITIVITY (Worsened her allergies), FEELING ABNORMAL (brain fogged), ILLNESS (Felt sick) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information were provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Outcome of event fatigue was updated.